Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Women with heart disease may be at increased risk for advanced breast cancer, a new study finds.Researchers reviewed data from more than 19,000 patients and fou ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...